As COVAX vaccines reach rural Batsumber in Mongolia, livestock herders hope that the loneliness of the pandemic era will soon come to an end.
13 Jul 2021 | 4:11
As India celebrated its one-billionth COVID-19 vaccination, #VaccinesWork caught up with Anuradha Gupta, Gavi’s Deputy CEO and an Indian public health veteran.
Welcome to Pandemica, a world where twice as many people die and life as we once knew it does not return for anyone.
Despite the havoc wrought by the COVID-19 pandemic on health systems worldwide, governments’ work to bring immunisation programmes back on track is paying off.
A study looking at health issues such as stroke or seizures after COVID-19 vaccination showed that vaccines weren’t linked to any significant number of side effects.
Data from the UK suggests double vaccination lowers the risk of ongoing COVID-19 symptoms, as well as reducing hospitalisations and the severity of the initial illness.
More often than not, the road to a meaningful triumph is a bumpy one.
While most people jumped at the chance to get their COVID-19 vaccine, some have been more hesitant over concerns about safety. Here we explain all the checks and balances in place to make sure the vaccines are safe.
COVID-19 has caused a decline in the delivery of human papillomavirus (HPV) vaccines that protect girls from cervical cancer. Anuradha Gupta, the Deputy CEO of Gavi, explains what we must do to create more access to these vaccines.
The way we live can shape the evolution of pathogens, for better or worse.
Real-world data is starting shed light on the performance of COVID-19 vaccines in less than perfect conditions.
The Immunization Agenda 2030’s new scorecard visualizes a journey toward pandemic recovery and global immunization progress.
For years, a growing number of infections that are resistant to antimicrobials has offered us a grim glimpse into a future with increasingly untreatable diseases. Now, COVID-19 has made antimicrobial resistance so much worse.